| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/07/2006 | EP1666057A2 An acellular vaccine comprising Bordetella pertussis antigens |
| 06/07/2006 | EP1666056A1 Cancer vaccine vesicles |
| 06/07/2006 | EP1666052A1 Uses of agonists and antagonists to modulate activity of TNF-related molecules |
| 06/07/2006 | EP1666047A1 Pharmaceutical compositions comprising nitric oxide-releasing pyrrolidones |
| 06/07/2006 | EP1666039A1 Use of L-alpha-lysophosphatidylcholine inhibitors to prevent inflammation |
| 06/07/2006 | EP1666028A1 Dry powder compositions having improved dispersivity |
| 06/07/2006 | EP1664719A2 Methods for substantially simultaneous evaluation of a sample containing a cellular target and a soluble analyte |
| 06/07/2006 | EP1664319A2 Process for producing a capsular polysaccharide for use in conjugate vaccines |
| 06/07/2006 | EP1664317A2 Method for obtaining precursor z and use thereof for the production of a means for therapy of human molybdenum cofactor deficiency |
| 06/07/2006 | EP1664270A1 Chimeric antigens for breaking host tolerance to foreign antigens |
| 06/07/2006 | EP1664268A2 Compositions and methods for inhibiting white spot syndrome virus (wssv) infection |
| 06/07/2006 | EP1664127A1 Synthetic polysaccharide antigens for immunological intervention in disease |
| 06/07/2006 | EP1664124A2 Product comprising a c4bp core protein and a monomeric antigen, and its use |
| 06/07/2006 | EP1664117A2 Immunogen |
| 06/07/2006 | EP1664100A2 Lawsonia intracellularis subunit vaccine |
| 06/07/2006 | EP1664099A2 Adenoviral epitopes |
| 06/07/2006 | EP1664097A2 Piroplasmid vaccine |
| 06/07/2006 | EP1664082A2 Kid3 and kid3 antibodies that bind thereto |
| 06/07/2006 | EP1664075A2 Methods for diagnosing and treatment of conditions that alter phosphate transport in mammals |
| 06/07/2006 | EP1663309A2 Methods and compositions for treating herpes infections |
| 06/07/2006 | EP1663308A1 Compositions and methods to accelerate hematologic recovery |
| 06/07/2006 | EP1663304A2 Treatment of rheumatoid arthritis with cd99 antagonists |
| 06/07/2006 | EP1663303A2 Immunogenic compositions for streptococcus agalactiae |
| 06/07/2006 | EP1663302A2 Method for vaccination of poultry by bacteriophage lysate |
| 06/07/2006 | EP1663301A1 Vaccines |
| 06/07/2006 | EP1663300A1 Inhibitors of pace4 for the treatment of arthritis |
| 06/07/2006 | EP1663290A2 Modulators of p-selectin glycoprotein ligand 1 |
| 06/07/2006 | EP1663146A2 Method for production of bioresorbable microparticles microparticles thus obtained and use thereof |
| 06/07/2006 | EP1663111A2 Delivery of physiologixal agents with in-situ gels comprising anionic polysaccharides |
| 06/07/2006 | EP1663104A2 Porifera-based therapeutic compositions for treating and preventing skin diseases |
| 06/07/2006 | EP1476467B1 Immunoglobulin igg3 as a marker for protecting against infectious viral diseases, and the uses of the same |
| 06/07/2006 | EP1409673B1 Human leucine-rich repeat containing protein, expressed predominantely in small intestine, hlrrsi1 |
| 06/07/2006 | EP1364023B1 Gene highly expressed in cartilage tissues |
| 06/07/2006 | EP1320552B8 Method for producing human anti-thymocyte immunoglobulins |
| 06/07/2006 | EP1274725B1 Use of hev polypeptides |
| 06/07/2006 | EP1265630B1 Use of insulin for the treatment of cartilagenous disorders |
| 06/07/2006 | EP1254234B1 Haemophilus influenza outer membrane protein and use thereof in vaccination |
| 06/07/2006 | EP1174126B1 Antibody and polyalkylene glycol-bonded liposome |
| 06/07/2006 | EP1104307B1 Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix |
| 06/07/2006 | EP1095059B1 Chemotaxis inhibiting protein of staphylococcus (chips) and its use |
| 06/07/2006 | EP1051620B1 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha |
| 06/07/2006 | EP1045698B1 Patient-specific white blood cell malignancy vaccine from membrane-proteoliposomes |
| 06/07/2006 | EP1002081B1 Delayed progression to aids by a missense allele of the ccr2 gene |
| 06/07/2006 | EP0969873B1 Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof |
| 06/07/2006 | EP0871735B1 Therapeutic compositions for the treatment of Lawsonia intracellularis infections |
| 06/07/2006 | EP0813538B1 Compositions and methods for the treatment and diagnosis of immune disorders |
| 06/07/2006 | EP0772437B1 Compositions for delivery of genetic material |
| 06/07/2006 | CN1784426A Antibody targeted at antigen specific to cancer |
| 06/07/2006 | CN1784425A Method of detecting probnp with a monoclonal antibody binding to the amino acids 38-44 |
| 06/07/2006 | CN1784424A Synthetic gene encoding human carcinoembryonic antigen and uses thereof |
| 06/07/2006 | CN1784422A Severe acute respiratory syndrome (SARS) causing coronavirus |
| 06/07/2006 | CN1784421A Immunogenic human TNF alpha analogues with reduced cytotoxicity and methods of their preparation |
| 06/07/2006 | CN1784419A Streptococcus agalactiae antigens i + ii |
| 06/07/2006 | CN1784242A A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis |
| 06/07/2006 | CN1784240A Alzheimer's disease treatment method |
| 06/07/2006 | CN1782078A Heavy Chain and light chain variable area gene of mouse antihuman lipopolysaccharide acceptor antibody and its use |
| 06/07/2006 | CN1782077A HAb18Gedomab 1 monoclonal antibody and its light and heavy chain variable area genes, coding polypeptide and use |
| 06/07/2006 | CN1782071A Recombinant mva virus and the use thereof |
| 06/07/2006 | CN1781934A HER-2 analogue antigen epitope and peptide containing said epitope |
| 06/07/2006 | CN1781930A Deoxy nucleotide containing CpG single chain as adjuvant of hepatitis B virus vaccine |
| 06/07/2006 | CN1781929A Deoxy nucleotide containing CpG single chain as adjuvant of rabies vaccine |
| 06/07/2006 | CN1781553A Subunit vaccine of H5N1 subtype bird flu virus gene ergineering and its preparing method |
| 06/07/2006 | CN1781552A Stenotrophomonasmal-tophilia vaccine and its preparing method |
| 06/07/2006 | CN1258596C Leporipox-based vector vaccines |
| 06/07/2006 | CN1258563C Highly-neutralized ethylene copolymers and their use in golf balls |
| 06/07/2006 | CN1258539C Compositions and methods for generating monoclonal antibodies representative of a specific cell type |
| 06/07/2006 | CN1258538C Recombinant protein |
| 06/07/2006 | CN1258537C Method for preparing polypeptide soluble in aqueous solvent in absence of detergent |
| 06/07/2006 | CN1258381C Botulinum toxin in the treatment or prevention of acne |
| 06/07/2006 | CN1258379C Botulinum toxin pharmaceutical composition |
| 06/06/2006 | US7057022 Antibodies which specifically bind to TNF-R |
| 06/06/2006 | US7056909 5,5-Difluoro-3(S)-(pyrimidin-5-yl)-9-(5,6,7,8-tetrahydro-(1, 8)-naphthyridin-2-yl)-nonanoic acid; inhibition of bone resorption, restenosis, angiogenesis, retinopathy, macular degeneration, arthritis, metastatic tumor growth, etc. |
| 06/06/2006 | US7056901 Microgel particles for the delivery of bioactive materials |
| 06/06/2006 | US7056885 Fibroblast growth factor and nucleic acids encoding same |
| 06/06/2006 | US7056733 Comprises nucleotide sequences coding parasite membrane protein for use in generating immunoglobulins to prevent equine protozoal myeloencephalitis (EPM); veterinary medicine |
| 06/06/2006 | US7056723 High pressure homogenizing; vaccinia virus; ultrafiltration; chromatography |
| 06/06/2006 | US7056720 LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies |
| 06/06/2006 | US7056702 Immunoglobulin for detecting inflammation and bacterial infections in mammals |
| 06/06/2006 | US7056701 Hormone and albumin fusion protein |
| 06/06/2006 | US7056700 Use of ClyA hemolysin for excretion of proteins |
| 06/06/2006 | US7056697 FabK variant |
| 06/06/2006 | US7056692 Modulation of pleiotrophin signaling by receptor-type protein tyrosine phosphatase beta/zeta |
| 06/06/2006 | US7056689 Methods of treating and detecting cancer using viruses |
| 06/06/2006 | US7056658 Epitope sequence for use as tool in diagnostic analysis |
| 06/06/2006 | US7056521 Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants |
| 06/06/2006 | US7056519 Methods for inducing HIV-neutralizing antibodies |
| 06/06/2006 | US7056518 Malarial pre-erythrocytic stage polypeptide molecules |
| 06/06/2006 | US7056517 Glucosyltransferase immunogens |
| 06/06/2006 | US7056516 Comprises nucleotide sequences coding caspase 8 inhibitory protein for use in the treatment of alzheimer's, parkinson's, arthritic, septic, cardiovascular, inflammatory, osteoporotic and ischemic reperfusion injuries/disorders |
| 06/06/2006 | US7056515 Antigens for immunocontraception |
| 06/06/2006 | US7056514 Partial peptide mimetics and methods |
| 06/06/2006 | US7056513 Peptides for use in the treatment of cancer and aging |
| 06/06/2006 | US7056512 controlling and increasing muscle growth, especially in farm animals for slaughter, by administering an immunogenically effective amount ofa modified GDF-8 polypeptide |
| 06/06/2006 | US7056510 Streptococcus pneumoniae SP036 polynucleotides, polypeptides, antigens and vaccines |
| 06/06/2006 | US7056509 Monoclonal antibodies used as antagonists vascular endothelial growth factors (VEGF); angiogenesis inhibitors; antitumor agents |
| 06/06/2006 | US7056508 Receptor-type phosphotyrosine phosphatase-kappa antibodies |
| 06/06/2006 | US7056507 Adsorbent for eliminating hepatitis C virus, adsorber, and adsorption method |
| 06/06/2006 | US7056506 Methods for detecting and inhibiting angiogenesis |
| 06/06/2006 | US7056505 Antibody for use in the diagnosis, prevention and treatment of infections, autoimmune disorders, arthritis, graft rejection and graft-versus-host disease |
| 06/06/2006 | US7056501 used to develop diagnostic assays for the detection of Neospora infections in cattle and other animals |